Aarey Drugs & Pharmaceuticals shares fall 1.07% as regulatory disclosure under Regulation 29(1) received for Nimit Rajesh Ghatalia
Why did Aarey Drugs & Pharmaceuticals Ltd shares fall today?
Aarey Drugs & Pharmaceuticals Ltd shares were trading at ₹101.95 as of Monday, 11:30 AM, reflecting a decline of 1.07% from the previous closing price. The dip in the stock price came after the stock exchange received an important regulatory disclosure related to a potential change in the company's shareholding structure.
According to the details, the Exchange has received a disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, concerning Nimit Rajesh Ghatalia. This regulation requires a person or entity to disclose their intention to acquire substantial shares in a listed company when their holding crosses a certain threshold. The disclosure carries the PAN number BBCPG4901J, indicating that the acquiring entity or individual has formally informed the exchange about their plans.
Such regulatory disclosures often create uncertainty among investors, as they signal potential changes in the company's ownership pattern. The market may react negatively to this news due to concerns about dilution of existing shareholders' stake or uncertainty about the acquirer's future intentions. As a result, selling pressure built up in the stock, leading to the 1.07% decline in Aarey Drugs & Pharmaceuticals Ltd shares by mid-morning trading. Investors are advised to closely watch subsequent developments from the company and SEBI regarding this disclosure before making any investment decisions.
What does Aarey Drugs & Pharmaceuticals Ltd do?
Aarey Drugs & Pharmaceuticals Ltd is a pharmaceutical company engaged in the manufacture and supply of drugs and pharmaceutical products. As its name indicates, the company operates within the pharmaceutical sector, focusing on the production and distribution of medicine-related products.
The company holds the Corporate Identity Number BBCPG4901J, indicating its registration as a formally incorporated corporate entity. Through its pharmaceutical operations, Aarey Drugs & Pharmaceuticals Ltd contributes to the supply chain of healthcare products, delivering drugs to support public health needs in its market.
Aarey Drugs & Pharmaceuticals Ltd Financials
In CroresAarey Drugs & Pharmaceuticals Ltd reported revenue of ₹189.47 Crores for the period ending March 2026, against which it earned a profit of ₹1.56 Crores, implying a net margin of roughly 0.82%. For the period ending June 2026, revenue stood at ₹44.63 Crores with a profit of ₹1.02 Crores, translating into a net margin of approximately 2.29%. It should be noted that the June 2026 figure appears to represent a single quarter rather than a full financial year, so a direct period-on-period comparison with the annual March 2026 numbers would not be strictly like-for-like. On an absolute basis, both revenue and profit declined from March 2026 to June 2026, but this largely reflects the shorter reporting period. On a profitability basis, the company's net margin improved materially, from under 1% to over 2%, suggesting that the June 2026 quarter was relatively more profitable despite lower absolute revenue. Overall, the company remained profitable in both periods, and while the revenue scale in June 2026 was lower than the March 2026 full-year figure, the profitability per rupee of revenue generated was noticeably higher.
Aarey Drugs & Pharmaceuticals Ltd Shareholding Pattern
Promoter holding stands at 37.71% of the total share capital. Foreign Institutional Investors (FIIs) hold 4.81% stake in the company, while Domestic Institutional Investors (DIIs) hold 1.62%. Public shareholders hold the remaining 55.87% stake in Aarey Drugs & Pharmaceuticals Ltd.
Aarey Drugs & Pharmaceuticals Ltd FAQs
Q: Why did Aarey shares fall 1.07% today?
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nimit Rajesh Ghatalia. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Aarey Drugs & Pharmaceuticals Ltd?
As per the latest data, promoters hold 37.71% stake in Aarey Drugs & Pharmaceuticals Ltd, while FII holding stands at 4.81%. Domestic institutional investors hold 1.62%, and public shareholders account for 55.87% of the equity.
Q: What is the current stock price of Aarey Drugs & Pharmaceuticals Ltd?
Aarey Drugs & Pharmaceuticals Ltd shares are currently trading at ₹101.95, recording a decline of 1.07% from the previous close.
Q: What is the market capitalization of Aarey Drugs & Pharmaceuticals Ltd?
The company currently has a market capitalization of ₹340.05 crore, reflecting its valuation in the Indian equity market.